• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Second Overseas Innovative Medical Device in 2020 Approved via Green Channel

Second Overseas Innovative Medical Device in 2020 Approved via Green Channel

Overseas Innovative Medical Device Fast-Track Approval
Wednesday, 03 June 2020 / Published in Medical Device

Second Overseas Innovative Medical Device in 2020 Approved via Green Channel

On 14.05.2020, the NMPA (National Medical Products Administration) granted the fast-track approval to the global oncology firm Novocure for the registration of Optune, the first tumor-treating fields device to be approved in China to treat glioblastoma.

Optune is only applicable to treat patients, aged 22 or over, with histologically-confirmed glioblastoma multiforme (GBM). Also, it is the first device in China to utilize electric fields for cancer therapy by tuning specific frequencies to disrupt cell division, whilst causing minimal damage to healthy cells.

After the fast-track approval of this new innovative medical device in China, the NMPA will continue to strengthen its measures for post-market surveillance.

On 23.04.2020, the CMDE (Center for Medical Device Evaluation) of NMPA (National Medical Products Administration) announced (No.5-2020) the fast-track approval for Edwards Lifesciences’ transcatheter valve repair clip device, utilizing the special review procedure.

There are three types of fast track channels to encourage innovation and deal with unmet medical needs in China: Innovation Approval, Priority Review, and Emergency Approval. Feel free to request a quotation from us to check if your product qualifies for NMPA registration via a fast track channel.

By Jacky Li. Contact Cisema to learn more.

Tagged under: fast-track approval, Green Channel, innovative medical device

What you can read next

Clinical trials of sodium hyaluronate complex solution
Clinical trials of sodium hyaluronate complex solution – draft guidelines issued
Supervision and administration of medical devices
Supervision and administration of medical device – sampling inspections finds 12 product failures
1,002 Institutions in China Qualified for Clinical Trials

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Physicochemical characterization of nanomaterials

    Physicochemical characterization of nanomaterials used in medical devices – New guidelines issued

    Physicochemical characterization of nanomateria...
  • Registration of disposable light-proof infusion sets in China

    Registration of disposable light-proof infusion sets in China – Amended guidelines issued

    Registration of disposable light-proof infusion...
  • Registration of disposable blood separation devices in China

    Registration of disposable blood separation devices in China – Amended guidelines issued

    Registration of disposable blood separation dev...
  • Registration of disposable infusion devices in China

    Registration of disposable infusion devices in China – Amended guidelines issued

    Registration of disposable infusion devices in ...
  • Registration of blood dialyzers in China

    Registration of blood dialyzers in China – Amended guidelines issued

    Registration of blood dialyzers in China shall ...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP